Nurix Therapeutics, Inc. , a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases.
Nurix Therapeutics stock last closed at $26.80, down 1.18% from the previous day, and has increased 109.7% in one year. It has overperformed other stocks in the Biotechnology industry by 1.76 percentage points. Nurix Therapeutics stock is currently +129.65% from its 52-week low of $11.67, and -5.07% from its 52-week high of $28.23.
As of Oct 30, 2026, there are 109.25M shares of NRIX outstanding. The market cap of NRIX is $2.93B. In the last 24 hours, 2.31M NRIX shares were traded.
How to Buy Nurix Therapeutics Stock
Wondering how to invest in Nurix Therapeutics stock? Here's how.
Decide where to buy Nurix Therapeutics stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you decide where to buy Nurix Therapeutics stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Select your method of payment and add your information.
Research Nurix Therapeutics stock: The Nurix Therapeutics ticker symbol is NRIX. Is Nurix Therapeutics stock a good investment? Should you buy shares of NRIX? How do NRIX's underlying business fundamentals look? Do top analysts think Nurix Therapeutics is a good buy? Why has NRIX's stock price moved recently? (Hint: Our stock market research tools can help you decide if NRIX is a good stock to buy).
Place your NRIX purchase: Decide if you will purchase NRIX shares at the current market price or use a limit order to purchase NRIX stock at a specific price.
Get updates on your investment in NRIX: Create a watchlist to get the latest news on your position in Nurix Therapeutics stock.
Step 1: Decide where to buy Nurix Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy NRIX stock.
A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world markets: From Tech to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal info so you can buy NRIX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Nurix Therapeutics stock
After you have decided on the best place to buy Nurix Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.
Nurix Therapeutics Metrics
NRIX Price
$26.80
1w %
5.76%
1y %
109.7%
5y %
-22.32%
P/E
10.72x
P/B
3.02x
P/S
4.26x
PEG
N/A
Revenue
$701.94M
Earnings
$294.88M
Fore. Rev. Growth
-43.38%
Fore. Earn. Growth
N/A
Market Cap
$2.93B
Next Earnings
N/A
Next Dividend
N/A
NRIX Due Diligence Checks
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.
There are more short-term assets than short-term liabilities on the NRIX balance sheet.
NRIX earnings of $308.21M is not sufficient to cover its interest payments.
Total NRIX debt is lower than 5 years ago, relative to shareholder equity.
NRIX has a low debt to equity ratio of 0.23.
There are more short-term assets than long-term liabilities on the NRIX balance sheet.
NRIX's operating cash flow of $379.31M allows it to safely service it's debt of $65.33M.
NRIX profit margin has gone up from -292.5% to 42% in the past year.
Do Wall Street analysts think it's a good time to buy Nurix Therapeutics stock
Out of 13 Wall Street analysts who give forecasts on NRIX, the consensus analyst rating on Nurix Therapeutics is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest NRIX Analyst Forecasts
Gil Blum, a top 3% analyst from Needham reiterates NRIX with a buy rating and maintains their NRIX price target from $34.00 to $34.00, on Oct 13, 2026.
Terence Flynn, a top 4% analyst from Morgan Stanley maintains NRIX with a strong buy rating and raises their NRIX price target from $36.00 to $38.00, on Jul 28, 2026.
Morgan Stanley's Terence Flynn raised their price target on Nurix Therapeutics (NASDAQ: NRIX) by 5.6% from $36 to $38 on 2026/07/28. The analyst maintained their Strong Buy rating on the stock.
Flynn said their price target hike on Nurix Therapeutics was catalyzed by benefits from recently-closed Roche* collaboration.
Footnotes
* Roche trades under the ticker, RHHBY, on the over-the-counter market through the OTCQX International Premier tier in theU.S. Its primary underlying shares and participation certificates trade on the SIX Swiss Exchange under the symbols RO and ROP.
David Dai, a bottom 7% analyst from UBS maintains NRIX with a strong buy rating and raises their NRIX price target from $23.00 to $31.00, on Jul 22, 2026.
Joseph Catanzaro, a top 18% analyst from Mizuho maintains NRIX with a buy rating and raises their NRIX price target from $30.00 to $34.00, on Jul 13, 2026.
Stephen Willey, a top 22% analyst from Stifel Nicolaus maintains NRIX with a strong buy rating and raises their NRIX price target from $34.00 to $40.00, on Jul 10, 2026.
Last year, NRIX revenue was $701.94M. During the last 5 year, NRIX's revenue has increased by 89.08% per year. This was faster than the Biotechnology industry average of 30.09%.
No, Nurix Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about NRIX?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your NRIX purchase
There are two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly the easiest way to buy.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a given dollar amount, use a limit order.
Hit the Open button and eToro will place your order.
If you require additional assistance investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Nurix Therapeutics share?
As of Oct 30, 2026, it costs $26.80 to buy one share of Nurix Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.373 shares of NRIX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.